Literature DB >> 30032846

Log odds of positive lymph nodes may predict survival benefit in patients with node-positive non-small cell lung cancer.

Weiye Deng1, Ting Xu1, Yifan Wang2, Yujin Xu3, Pei Yang4, Daniel Gomez1, Zhongxing Liao5.   

Abstract

OBJECTIVES: The number of positive lymph nodes (npLNs) and the lymph node ratio [LNR; npLNs/number of resected LNs] are useful for predicting survival among patients with non-small cell lung cancer (NSCLC). Here we compared the relative effectiveness of npLNs, LNR, and the log odds of positive lymph nodes (LODDS) to predict overall survival (OS) and cancer-specific survival (CSS) among patients with node-positive NSCLC.
MATERIALS AND METHODS: We identified 5289 patients with NSCLC and lymph node involvement who had lobectomy or pneumonectomy in 2010-2013 from the Surveillance Epidemiology and End Results (SEER) database. Potential associations between npLNs, LNR, and LODDS with overall survival (OS) and cancer-specific survival (CSS) were assessed with Cox regression analysis. The goodness of fit of npLNs, LNR, and LODDS was compared with the -2 log-likelihood ratio (-2LLR) and by differences in Akaike's information criterion scores (ΔAIC). Tree-based recursive partitioning was applied to split ratio-based variables (LNR and LODDS) into low- and high-risk groups. Kaplan-Meier actuarial estimates of OS and CSS in the various npLNs, LNR, and LODDS subgroups were compared with log-rank tests. RESULTS AND
CONCLUSION: Of 5289 patients, 2297 (43.3%) had <10 LNs retrieved and 2992 (56.6%) had ≥10 LNs harvested. Multivariate Cox analysis adjusted for significant factors indicated that LODDS, npLNs, and LNR were independent risk factors for OS and CSS. A LODDS model had the best fit compared with LNR or npLN models in predicting OS and CSS (P < 0.001, ΔAIC = 0). LODDS was slightly superior to LNR for patients with <10 resected LNs, and LNR was slightly superior to LODDS for patients with ≥10 resected LNs (P < 0.001). Higher LODDS was associated with worse OS and worse CSS (log-rank P for both <0.001). LODDS and LNR staging schemes outperformed those of npLNs for predicting OS and CSS. Published by Elsevier B.V.

Entities:  

Keywords:  LODDS; Lymph node ratio; Non-small cell lung cancer; SEER database

Mesh:

Year:  2018        PMID: 30032846     DOI: 10.1016/j.lungcan.2018.05.016

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  14 in total

1.  Does anatomical location-based metastatic lymph node density affect prognosis in lung cancer patients?

Authors:  Yunus Aksoy; Necati Çıtak; Çiğdem Obuz; Muzaffer Metin; Adnan Sayar
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-10-04

2.  Log odds of positive lymph nodes is a better prognostic factor for oesophageal signet ring cell carcinoma than N stage.

Authors:  Feng Wang; Shu-Geng Gao; Qi Xue; Feng-Wei Tan; Yu-Shun Gao; You-Sheng Mao; Da-Li Wang; Jun Zhao; Yin Li; Xiang-Yang Yu; Hong Cheng; Chen-Guang Zhao; Ju-Wei Mu
Journal:  World J Clin Cases       Date:  2021-01-06       Impact factor: 1.337

3.  A Machine Learning-Based Investigation of Gender-Specific Prognosis of Lung Cancers.

Authors:  Yueying Wang; Shuai Liu; Zhao Wang; Yusi Fan; Jingxuan Huang; Lan Huang; Zhijun Li; Xinwei Li; Mengdi Jin; Qiong Yu; Fengfeng Zhou
Journal:  Medicina (Kaunas)       Date:  2021-01-22       Impact factor: 2.430

4.  Nomogram to predict overall survival based on the log odds of positive lymph nodes for patients with endometrial carcinosarcoma after surgery.

Authors:  Linzhi Gao; Jun Lyu; Xiaoya Luo; Dong Zhang; Guifang Jiang; Xian Zhang; Xuesong Gao; Shaolie Zheng; Xiaoyu Wang; Yuan Shen
Journal:  BMC Cancer       Date:  2021-10-27       Impact factor: 4.430

5.  Prognostic Performance of Different Lymph Node Staging Systems in Patients With Small Bowel Neuroendocrine Tumors.

Authors:  Sujing Jiang; Lihao Zhao; Congying Xie; Huafang Su; Ye Yan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-07       Impact factor: 5.555

6.  Validation of the prognostic value of various lymph node staging systems for cervical squamous cell carcinoma following radical surgery: a single-center analysis of 3,732 patients.

Authors:  Qinhao Guo; Jun Zhu; Yong Wu; Hao Wen; Lingfang Xia; Xingzhu Ju; Guihao Ke; Xiaohua Wu
Journal:  Ann Transl Med       Date:  2020-04

7.  Comparison of different lymph node staging systems in patients with node-positive cervical squamous cell carcinoma following radical surgery.

Authors:  Qinhao Guo; Jun Zhu; Yong Wu; Hao Wen; Lingfang Xia; Min Yu; Simin Wang; Xingzhu Ju; Xiaohua Wu
Journal:  J Cancer       Date:  2020-10-23       Impact factor: 4.207

8.  Prognostic value of log odds of positive lymph nodes in node-positive lung squamous cell carcinoma patients after surgery: a SEER population-based study.

Authors:  Yue Yu; Peng Zhang; Renqi Yao; Junnan Wang; Pei Wang; Xiaofei Xue; Jian Xiao; Zhinong Wang
Journal:  Transl Lung Cancer Res       Date:  2020-08

9.  Dynamic nomograms combining N classification with ratio-based nodal classifications to predict long-term survival for patients with lung adenocarcinoma after surgery: a SEER population-based study.

Authors:  Suyu Wang; Yue Yu; Wenting Xu; Xin Lv; Yufeng Zhang; Meiyun Liu
Journal:  BMC Cancer       Date:  2021-08-04       Impact factor: 4.430

10.  Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer.

Authors:  Xinyi Huang; Pingping Hu; Fei Yan; Jiandong Zhang
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.